SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2044Women Get Less Aggressive Heart Treatment-Study Tue Mar 9, 5:52 PM ET [This is Icebrg-3/10/2004
2043>>Apoptosis. 2004 Mar;9(2):149-55. 2-Methoxyestardiol and bortezomib/prtuck-3/9/2004
2042Report: Following guidelines saves lives Hospital Quality Initiative BY JIM SHIcebrg-3/9/2004
2041[Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy.] >&gtuck-2/27/2004
2040Deleted, sorrytuck-2/19/2004
2039Thanks Peter for the effort and the clarification. I'm slightly less disgusIan@SI-2/11/2004
2038But note that he was forced to exercise those shares (as the options expire in aBiomaven-2/11/2004
2037Edit: He just filed another 2 form 4s. 1 documented the sale of another 50,000Ian@SI-2/11/2004
2036Generex Appoints Dr. Douglas Powell as Director of Immunobiology Monday FebruaryIcebrg-2/9/2004
2035[MLN 4760: ACE2 inhibitor for SARS and cardiovascular indications] >>J Bituck-2/3/2004
2034ValuEngine Upgrades Primus, Everest Re, Millennium to '5' Rating ------manny t-2/2/2004
2033>>Mol Cancer Ther. 2004 Jan;3(1):59-70. The proteasome inhibitor borteztuck-1/31/2004
2032<i>[I picked up the following from the Yahoo! board]</i> Thanks forscaram(o)uche-1/30/2004
2031MLN944 [I picked up the following from the Yahoo! board] Mol Cancer Ther. 2004Icebrg-1/30/2004
2030Kailian filed a Form 4 to document the sale of 1/4 of his holding at $17.575 todIan@SI-1/30/2004
2029#2. Thanks.tom pope-1/29/2004
2028if twenty of us muck up the thread with "thanks", so be it. (eom)scaram(o)uche-1/28/2004
20271/28/04 conference call 1. 2003 highlights - - ken bate successful V launch; csoftware salesperson-1/28/2004
2026mlnm cfo ken b on CNBC this morning.mopgcw-1/28/2004
2025MLNM beats by a couple of pennies, as the end of the Bayer and Aventis alliancestuck-1/27/2004
2024VELCADE(TM) (Bortezomib) Recommended for European Marketing Approval Thursday JSemiBull-1/25/2004
2023Millennium floats 'unusual' spinoff plan Mark Hollmer Journal Staff CAMIcebrg-1/22/2004
2022From Yahoo - worth a read: I'm fianlly listening by: boronate 01/12/04 11:IRWIN JAMES FRANKEL-1/13/2004
2021Millennium focuses on cancer, cardio CFO sees growth for key Velcade, IntegrilinIcebrg-1/12/2004
2020Updated MLNM Corporate presentation available at: investor.millennium.com Some Ian@SI-1/12/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News